Immunotherapies in ovarian cancer
Ovarian cancer is the leading cause of death for gynaecological cancer, and new therapies are urgently awaited. Although the presence of tumour-infiltrating lymphocytes has been confirmed to be associated to a better prognosis, immunotherapy is not yet incorporated to the armamentarium in ovarian ca...
| Published in: | EJC Supplements |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-08-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1359634920300033 |